• Schedule 13D/G History

Flagship V VentureLabs Rx Fund, L.P. - Significant Ownership

Signature - Title
Flagship V VentureLabs Rx Fund, L.P. - Noubar B. Afeyan, Ph.D., Manager of General Partner
Location
Cambridge, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Flagship V VentureLabs Rx Fund, L.P..

Significant Ownership of Flagship V VentureLabs Rx Fund, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
OMGAQ OMEGA THERAPEUTICS, INC. Common Stock, $0.001 par value per share 52.8% $21.8K -$96.2K 29.2M 0% Noubar Afeyan Feb 3, 2025

Schedules 13D/G Reported by Flagship V VentureLabs Rx Fund, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.